<DOC>
	<DOCNO>NCT00002794</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . PURPOSE : Phase II trial study effectiveness carboplatin plus vincristine treating child retinoblastoma .</brief_summary>
	<brief_title>Carboplatin Plus Vincristine Treating Children With Retinoblastoma</brief_title>
	<detailed_description>OBJECTIVES : I . Estimate objective response rate infant child retinoblastoma treat carboplatin ( CBDCA ) vincristine ( VCR ) every 3 week 24 week . II . Assess success regimen delay radiotherapy eliminate need surgery estimate cumulative incidence function treatment failure . III . Estimate cumulative incidence failure regimen measure subsequent treatment radiotherapy surgery . OUTLINE : All patient receive carboplatin vincristine every 3 week maximum 8 course . Patients disease progression least 2 course remove study consider alternative therapy . Patients follow every 6 week 1 year , every 2 month 1 year , every 3-4 month 3 year , yearly 12 year . PROJECTED ACCRUAL : A total 25 patient accrue study within 4.5 year .</detailed_description>
	<mesh_term>Retinoblastoma</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Newly diagnose retinoblastoma Bilateral multifocal unilateral disease child age 10 Unilateral , multifocal tumor le 5 dd child age 2 No metastatic disease Disease evidence ophthalmoscopic/imaging exam , ultrasound , CT , MRI Fundus drawing photograph require PATIENT CHARACTERISTICS : Age : 10 Performance status : Not specify Life Expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy Endocrine therapy : Not specify Radiotherapy : No prior radiotherapy Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>intraocular retinoblastoma</keyword>
</DOC>